These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6818041)

  • 1. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. V. H-2 associativity of variant-specific antigens.
    Van Snick J; Maryanski J; Van Pel A; Parmiani G; Boon T
    Eur J Immunol; 1982 Nov; 12(11):905-8. PubMed ID: 6818041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones.
    Maryanski JL; Boon T
    Eur J Immunol; 1982 May; 12(5):406-12. PubMed ID: 6178608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. III. Clonal analysis of the syngeneic cytolytic T lymphocyte response.
    Maryanski JL; Van Snick J; Cerottini JC; Boon T
    Eur J Immunol; 1982 May; 12(5):401-6. PubMed ID: 6178607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. VII. Dominant expression of variant antigens in somatic cell hybrids.
    Maryanski JL; Szpirer J; Szpirer C; Boon T
    Somatic Cell Genet; 1983 May; 9(3):345-57. PubMed ID: 6407125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour cell variants with increased immunogenicity obtained by mutagen treatment.
    Boon T; Maryanski J
    Cancer Surv; 1985; 4(1):135-48. PubMed ID: 3879855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenic (tum-) variants obtained by mutagenesis of mouse mastocytoma P815. VIII. Detection of stable transfectants expressing a tum- antigen with a cytolytic T cell stimulation assay.
    Wölfel T; Van Pel A; De Plaen E; Lurquin C; Maryanski JL; Boon T
    Immunogenetics; 1987; 26(3):178-87. PubMed ID: 3114137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. VI. Occasional escape from host rejection due to antigen-loss secondary variants.
    Maryanski JL; Marchand M; Uyttenhove C; Boon T
    Int J Cancer; 1983 Jan; 31(1):119-23. PubMed ID: 6187698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis.
    Boon T; Van Snick J; Van Pel A; Uyttenhove C; Marchand M
    J Exp Med; 1980 Nov; 152(5):1184-93. PubMed ID: 6776227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual differences in the orientation of the cytolytic T cell response against mouse tumor P815.
    Brichard VG; Warnier G; Van Pel A; Morlighem G; Lucas S; Boon T
    Eur J Immunol; 1995 Mar; 25(3):664-71. PubMed ID: 7705394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal analysis of cytolytic T lymphocyte-mediated lysis of target cells with inducible antigen expression: correlation between antigen density and requirement for Lyt-2/3 function.
    Shimonkevitz R; Luescher B; Cerottini JC; MacDonald HR
    J Immunol; 1985 Aug; 135(2):892-9. PubMed ID: 2409156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
    Plata F; Jongeneel V; Cerottini JC; Brunner KT
    Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
    Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
    Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H2-restricted recognition of cloned HLA class I gene products expressed in mouse cells.
    Maryanski JL; Accolla RS; Jordan B
    J Immunol; 1986 Jun; 136(12):4340-7. PubMed ID: 3086429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation of specificity in cytolytic T lymphocyte clones: two broad specificity, H-2-independent recognition systems, one natural killer-like, develop during culture, in addition to the clonally distributed antigen-specific receptor.
    Wilson A; Shortman K
    Eur J Immunol; 1985 Sep; 15(9):899-905. PubMed ID: 2412835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human T cell recognition of cloned HLA class I gene products expressed on DNA transfectants of mouse mastocytoma P815.
    Maryanski JL; Moretta A; Jordan B; De Plaen E; Van Pel A; Boon T; Cerottini JC
    Eur J Immunol; 1985 Nov; 15(11):1111-7. PubMed ID: 2933264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice.
    Uyttenhove C; Van Snick J; Boon T
    J Exp Med; 1980 Nov; 152(5):1175-83. PubMed ID: 6776226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cytolytic T lymphocyte clones reactive with Moloney leukemia virus-associated antigens by monoclonal antibodies: a direct approach to the study of H-2 restriction.
    Weiss A; MacDonald HR; Cerottini JC; Brunner KT
    J Immunol; 1981 Feb; 126(2):482-5. PubMed ID: 6450244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific lysis of murine cells expressing HLA molecules by allospecific human and murine H-2-restricted anti-HLA T killer lymphocytes.
    Achour A; Begue B; Gomard E; Paul P; Sayagh B; Van Pel A; Levy JP
    Eur J Immunol; 1986 Jun; 16(6):597-604. PubMed ID: 3522244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance of metastatic tumor variants to tumor-specific cytotoxic T-lymphocytes not due to defects in expression of restricting major histocompatibility complex molecules in murine cells.
    Altevogt P; Leidig S; Heckl-Oestreicher B
    Cancer Res; 1984 Nov; 44(11):5305-13. PubMed ID: 6333273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.